BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Diagnosis
7 results:

  • 1. COL1A1::PDGFB fusion uterine sarcoma with a tert promoter mutation.
    Lu Y; Chen X; Zeng W; Hua P; Shen Y; Qiu Y; He X; Zhang H
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23210. PubMed ID: 37870859
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. LPCAT1-tert fusions are uniquely recurrent in epithelioid trophoblastic tumors and positively regulate cell growth.
    Oliver GR; Marcano-Bonilla S; Quist J; Tolosa EJ; Iguchi E; Swanson AA; Hoppman NL; Schwab T; Sigafoos A; Prodduturi N; Voss JS; Knight SM; Zhang J; Fadra N; Urrutia R; Zimmerman M; Egan JB; Bilyeu AG; Jen J; Veras E; Al-Safi R; Block M; Kerr S; Fernandez-Zapico ME; Schoolmeester JK; Klee EW
    PLoS One; 2021; 16(5):e0250518. PubMed ID: 34033669
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis.
    Gallagher CS; Mäkinen N; Harris HR; Rahmioglu N; Uimari O; Cook JP; Shigesi N; Ferreira T; Velez-Edwards DR; Edwards TL; Mortlock S; Ruhioglu Z; Day F; Becker CM; Karhunen V; Martikainen H; Järvelin MR; Cantor RM; Ridker PM; Terry KL; Buring JE; Gordon SD; Medland SE; Montgomery GW; Nyholt DR; Hinds DA; Tung JY; ; Perry JRB; Lind PA; Painter JN; Martin NG; Morris AP; Chasman DI; Missmer SA; Zondervan KT; Morton CC
    Nat Commun; 2019 Oct; 10(1):4857. PubMed ID: 31649266
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Different amplification patterns of 3q26 and 5p15 regions in cervical intraepithelial neoplasia and cervical cancer.
    Kudela E; Visnovsky J; Balharek T; Farkasova A; Zubor P; Plank L; Danko J
    Ann Diagn Pathol; 2018 Aug; 35():16-20. PubMed ID: 30072014
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Methylation of the hsa-miR-124, SOX1, tert, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
    Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
    Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
    Cardoso MFS; Castelletti CHM; Lima-Filho JL; Martins DBG; Teixeira JAC
    Mutat Res Rev Mutat Res; 2017 Jul; 773():161-173. PubMed ID: 28927526
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. uterine sarcomas and parasitic myomas after laparoscopic hysterectomy with power morcellation.
    Tan-Kim J; Hartzell KA; Reinsch CS; O'Day CH; Kennedy JS; Menefee SA; Harrison TA
    Am J Obstet Gynecol; 2015 May; 212(5):594.e1-10. PubMed ID: 25499259
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.